Wells Fargo & Company Corcept Therapeutics Inc Transaction History

Wells Fargo & Company

  • $429 Billion
  • Q1 2025

A detailed history of Wells Fargo & Company transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 110,563 shares of CORT stock, worth $7.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110,563
Previous 90,137 22.66%
Holding current value
$7.69 Million
Previous $4.54 Million 178.03%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$49.85 - $114.22 $1.02 Million - $2.33 Million
20,426 Added 22.66%
110,563 $12.6 Million
Q4 2024

Feb 12, 2025
BUY
$44.66 - $60.85 $2.06 Million - $2.8 Million
46,067 Added 104.53%
90,137 $4.54 Million
Q3 2024

Nov 13, 2024
BUY
$29.51 - $46.26 $92,867 - $145,580
3,147 Added 7.69%
44,070 $2.04 Million
Q2 2024

Aug 13, 2024
BUY
$22.21 - $34.48 $292,194 - $453,618
13,156 Added 47.38%
40,923 $1.33 Million
Q1 2024

May 10, 2024
SELL
$21.1 - $27.46 $674,419 - $877,703
-31,963 Reduced 53.51%
27,767 $699,000
Q4 2023

Feb 09, 2024
BUY
$24.82 - $32.88 $674,309 - $893,283
27,168 Added 83.43%
59,730 $1.94 Million
Q3 2023

Nov 13, 2023
SELL
$21.97 - $33.8 $646,115 - $994,024
-29,409 Reduced 47.46%
32,562 $887,000
Q2 2023

Aug 15, 2023
BUY
$21.44 - $25.15 $636,253 - $746,351
29,676 Added 91.89%
61,971 $1.38 Million
Q1 2023

May 12, 2023
BUY
$19.2 - $24.47 $343,641 - $437,964
17,898 Added 124.32%
32,295 $699,000
Q4 2022

Feb 13, 2023
BUY
$19.95 - $29.96 $46,244 - $69,447
2,318 Added 19.19%
14,397 $292,000
Q3 2022

Nov 14, 2022
SELL
$24.7 - $29.12 $14,869 - $17,530
-602 Reduced 4.75%
12,079 $309,000
Q2 2022

Aug 12, 2022
SELL
$17.33 - $25.3 $1.69 Million - $2.46 Million
-97,400 Reduced 88.48%
12,681 $302,000
Q1 2022

May 16, 2022
SELL
$16.53 - $25.21 $515,521 - $786,224
-31,187 Reduced 22.08%
110,081 $2.48 Million
Q4 2021

Feb 14, 2022
SELL
$17.1 - $23.34 $589,779 - $804,996
-34,490 Reduced 19.62%
141,268 $2.8 Million
Q3 2021

Nov 15, 2021
SELL
$19.68 - $22.53 $614,724 - $703,747
-31,236 Reduced 15.09%
175,758 $3.46 Million
Q2 2021

Aug 16, 2021
SELL
$19.97 - $24.43 $721,915 - $883,144
-36,150 Reduced 14.87%
206,994 $4.56 Million
Q1 2021

May 13, 2021
BUY
$23.49 - $30.56 $95,533 - $124,287
4,067 Added 1.7%
243,144 $5.79 Million
Q4 2020

Feb 09, 2021
SELL
$16.78 - $27.3 $1.43 Million - $2.33 Million
-85,196 Reduced 26.27%
239,077 $6.26 Million
Q3 2020

Nov 05, 2020
SELL
$12.46 - $19.98 $1.05 Million - $1.68 Million
-84,047 Reduced 20.58%
324,273 $5.64 Million
Q2 2020

Aug 13, 2020
BUY
$11.0 - $18.26 $2.09 Million - $3.47 Million
190,177 Added 87.18%
408,320 $6.87 Million
Q1 2020

May 14, 2020
BUY
$10.11 - $14.04 $2.21 Million - $3.06 Million
218,143 New
218,143 $2.59 Million

Others Institutions Holding CORT

# of Institutions
477
Shares Held
84M
Call Options Held
1.43M
Put Options Held
2.75M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.44B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email